Laurens F Reeskamp (G Kees Hovingh)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Drugs

The New England journal of medicine

Journal of the American Heart Association

European heart journal

Amsterdam UMC

UvA - AMC (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Amsterdam UMC Nov 01 2016

Netherlands

PhD candidate :: Vascular Medicine

Education History

UvA - AMC Sep 01 2009 - Sep 01 2016

Netherlands

MSC

Publications

Willemijn A M Schonck, Erik S G Stroes, G Kees Hovingh, Laurens F Reeskamp
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature. Drugs 84 (2) (2024)
Willemijn A M Schonck, Erik S G Stroes, G Kees Hovingh, Laurens F Reeskamp
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature. Drugs 84 (2) (2024)
Willemijn A M Schonck, Erik S G Stroes, G Kees Hovingh, Laurens F Reeskamp
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature. Drugs 84 (2) (2024)
Willemijn A M Schonck, Erik S G Stroes, G Kees Hovingh, Laurens F Reeskamp
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature. Drugs (2024)
Shirin Ibrahim, Nick S Nurmohamed, Didier Collard, Anouk de Weger, G Kees Kornelis Hovingh, Bert-Jan H Van Den Born, Laurens F Reeskamp, Erik S G Stroes, Tom F Brouwer
Association Between Self-Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension. Journal of the American Heart Association (2023)
Shirin Ibrahim, Jeroen van Rooij, Annemieke J M H Verkerk, Jard de Vries, Linda Zuurbier, Joep Defesche, Jorge Peter, Willemijn A M Schonck, Bahareh Sedaghati-Khayat, G Kees Kornelis Hovingh, Andre G Uitterlinden, Erik S G Stroes, Laurens F Reeskamp
Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia. Circulation. Genomic and precision medicine (2023)
Jordan M Kraaijenhof, Tycho R Tromp, Nick S Nurmohamed, Laurens F Reeskamp, Marije Langenkamp, Johannes H M Levels, S Matthijs Boekholdt, Nicholas J Wareham, Menno Hoekstra, Erik S G Stroes, G Kees Kornelis Hovingh, Aldo Grefhorst
ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity. Journal of the American Heart Association (2023)
Lianne R de Haan, Megan J Reiniers, Laurens F Reeskamp, Ali Belkouz, Lei Ao, Shuqun Cheng, Baoyue Ding, Rowan F van Golen, Michal Heger
Experimental Conditions That Influence the Utility of 2'7'-Dichlorodihydrofluorescein Diacetate (DCFH 2 -DA) as a Fluorogenic Biosensor for Mitochondrial Redox Status. Antioxidants (Basel, Switzerland) 11 (8) (2022)
Tycho R Tromp, G Kees Kornelis Hovingh, Laurens F Reeskamp
Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland". Arteriosclerosis, thrombosis, and vascular biology 42 (1) (2021)
Didier Collard, Nick S Nurmohamed, Yannick Kaiser, Laurens F Reeskamp, Tom Dormans, Hazra Moeniralam, Suat Simsek, Renee Douma, Annet Eerens, Auke C Reidinga, Paul W G Elbers, Martijn Beudel, Liffert Vogt, Erik S G Stroes, Bert-Jan H Van Den Born
Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study. BMJ open 11 (2) (2021)
Kausik K Ray, Laurens F Reeskamp, Ulrich Laufs, Maciej Banach, François Mach, Sadberk Lale Tokgözoğlu, Derek L Connolly, Anja J Gerrits, Erik S G Stroes, Lluis Masana, John J P Kastelein
Combination lipid-lowering therapy as first-line strategy in very high-risk patients. European heart journal (2021)
Frederick J Raal, Robert S Rosenson, Laurens F Reeskamp, John J P Kastelein, Paolo Rubba, Shazia Ali, Poulabi Banerjee, Kuo-Chen Chan, Daniel A Gipe, Nagwa Khilla, Robert Pordy, David M Weinreich, George D Yancopoulos, Yi Zhang, Daniel Gaudet, null null
Evinacumab for Homozygous Familial Hypercholesterolemia. The New England journal of medicine 383 (8) (2020)
Raul Dias Dos Santos Filho, Andrea Ruzza, Laurens F Reeskamp, Albert Wiegman, François Mach, Christopher E Kurtz, Andrew Hamer, Ian Bridges, Andrea Bartuli, Jean Bergeron, Tamás Szamosi, Saikat Santra, Claudia Stefanutti, Olivier S Descamps, Susanne Greber-Platzer, Ilse Luirink, John J P Kastelein, Daniel Gaudet, null null
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. The New England journal of medicine 383 (14) (2020)

Laurens F Reeskamp.css-eqlu8i{font-size:small;padding-left:4px;} (G Kees Hovingh)

Publication Activity (10 Years)

Top Topics

Top Venues

Laurens F Reeskamp (G Kees Hovingh)